Drugs / dAd5GNE
last change Jun 2012 re-read 3 minutes ago

dAd5GNE

Vaccine

Developed for
cocaine dependence
Investigated by
National Institute on Drug Abuse (NIDA) · Weill Medical College of Cornell University

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02455479 Jun 2012 → Dec 2026 expected cocaine dependence Weill Medical College of Cornell University Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as dAd5GNE ClinicalTrials.gov intervention name — accepted as the source's own label NCT02455479 ↗
Modality Vaccine “an anti-cocaine vaccine called dAd5GNE” NCT02455479 ↗